Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

10.6K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.6K
Necrosis01:16

Necrosis

6.9K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring attitudes and acceptance of artificial intelligence in multiple sclerosis from the patient perspective.

PLOS digital health·2026
Same author

Etiology- and age-specific timing of death by neurologic criteria evaluation and declaration in clinical practice.

Critical care (London, England)·2026
Same author

Variability in Key Physiological Parameters in Neurocritical Stroke Patients: A Multicenter Observational Study.

Journal of clinical medicine·2026
Same author

Delayed Care in Self-Presenting Stroke Patients: Real-World Data on Process Delays-Comparing Process Times Between Emergency Medical Services and Self-Presentation.

Journal of clinical medicine·2026
Same author

IV Thrombolysis Facilitates Interventional Reperfusion in Non-Cardioembolic but Not Cardioembolic Stroke.

Annals of clinical and translational neurology·2026
Same author

Neurocardiac Autonomic Dysfunction in Patients With Post-COVID-19 Condition: A Systematic Review and Meta-Analysis.

European journal of neurology·2026

Related Experiment Video

Updated: Mar 1, 2026

2-Vessel Occlusion/Hypotension: A Rat Model of Global Brain Ischemia
09:29

2-Vessel Occlusion/Hypotension: A Rat Model of Global Brain Ischemia

Published on: June 22, 2013

20.8K

Programmed Cell Death after Intracerebral Hemorrhage.

Tobias Bobinger1, Petra Burkardt1, Hagen B Huttner1

  • 1Department of Neurology, University of Erlangen-Nuremberg, Schwabachanlage 6, Erlangen 91054, Germany.

Current Neuropharmacology
|June 3, 2017
PubMed
Summary

Intracerebral hemorrhage (ICH) causes significant brain injury and cell death. While preclinical studies show promise for neuroprotective treatments, clinical trials have yet to confirm efficacy, highlighting the need for further research into programmed cell death pathways.

Keywords:
Cell deathICHapoptosisintracerebral hemorrhagenecrosispyroptosis.

More Related Videos

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
11:32

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke

Published on: January 3, 2025

1.7K
Author Spotlight: Imaging Pericytes Post-Subarachnoid Hemorrhaging in Rodents
05:11

Author Spotlight: Imaging Pericytes Post-Subarachnoid Hemorrhaging in Rodents

Published on: August 18, 2023

1.7K

Related Experiment Videos

Last Updated: Mar 1, 2026

2-Vessel Occlusion/Hypotension: A Rat Model of Global Brain Ischemia
09:29

2-Vessel Occlusion/Hypotension: A Rat Model of Global Brain Ischemia

Published on: June 22, 2013

20.8K
Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
11:32

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke

Published on: January 3, 2025

1.7K
Author Spotlight: Imaging Pericytes Post-Subarachnoid Hemorrhaging in Rodents
05:11

Author Spotlight: Imaging Pericytes Post-Subarachnoid Hemorrhaging in Rodents

Published on: August 18, 2023

1.7K

Area of Science:

  • Neuroscience
  • Stroke Research
  • Cellular Pathology

Background:

  • Intracerebral hemorrhage (ICH) is a severe stroke type with high mortality.
  • ICH causes primary mechanical brain injury and secondary injury via inflammation and cell dysfunction.
  • Programmed cell death, beyond necrosis, occurs after ICH.

Purpose of the Study:

  • To review current knowledge on programmed cell death pathways following ICH.
  • To analyze advances in preclinical and clinical ICH research.
  • To identify potential therapeutic targets for reducing ICH-related mortality and morbidity.

Main Methods:

  • Comprehensive literature review of recent preclinical and clinical studies on ICH.
  • Analysis of findings related to neuronal cell death mechanisms.
  • Evaluation of the translation of preclinical results to clinical trials.

Main Results:

  • Current ICH treatment focuses on blood pressure management and anticoagulant reversal.
  • Preclinical studies suggest anti-oxidative and anti-inflammatory treatments reduce neuronal death, but clinical trials have failed.
  • The timing of therapeutic intervention and non-apoptotic programmed cell death are critical considerations.

Conclusions:

  • Understanding programmed cell death pathways is crucial for developing new ICH therapies.
  • Preclinical findings, while not always clinically confirmed, advance our knowledge of ICH pathology.
  • Further research may lead to improved treatments, reduced mortality, and better quality of life for ICH patients.